Cycloalkane analogues of sinefungin as EHMT1/2 inhibitors

被引:11
|
作者
Liu, Qing [1 ,2 ,3 ]
Cai, Xiaoqing [2 ,3 ]
Yang, Dehua [2 ,3 ]
Chen, Yi [4 ]
Wang, Yafang [4 ]
Shao, Liming [1 ]
Wang, Ming-Wei [1 ,2 ,3 ,4 ]
机构
[1] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
[3] Natl Ctr Drug Screening, Shanghai 201203, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Methyltransferase inhibitor; Cycloalkyl substituted analogue; Natural product; Sinefungin; METHYLTRANSFERASE G9A; GLP; METHYLATION; MECHANISM;
D O I
10.1016/j.bmc.2017.06.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of cycloalkyl substituted analogues of the natural product sinefungin lacking the amino-acid moiety was designed and synthesized. Two stereoisomers (6-R and 6-S) were separated and their bioactivities examined against EHMT1/2. Of which, compound 14d showed an inhibitory activity against EHMT1/2 (88.9%, IC50 = 21.8 mu M for EHMT1 and 77.6%, IC50 = 39.6 mu M for EHMT2, respectively) similar to that of sinefungin (100.0%, IC50 = 28.4 mu M for EHMT1 and 79.5%, IC50 = 30.1 mu M for EHMT2, respectively). Further studies against other methyltransferases such as PRMT1 showed no activity except that 12d displayed about 20% inhibition. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4579 / 4594
页数:16
相关论文
共 50 条
  • [41] EHMT1 mosaicism in apparently unaffected parents is associated with autism spectrum disorder and neurocognitive dysfunction
    de Boer, Anneke
    Vermeulen, Karlijn
    Egger, Jos I. M.
    Janzing, Joost G. E.
    de Leeuw, Nicole
    Veenstra-Knol, Hermine E.
    den Hollander, Nicolette S.
    van Bokhoven, Hans
    Staal, Wouter
    Kleefstra, Tjitske
    MOLECULAR AUTISM, 2018, 9
  • [42] Analysis of EHMT1 expression and its correlations with clinical significance in esophageal squamous cell cancer
    Guan, Xiaojiao
    Zhong, Xinwen
    Men, Wanfu
    Gong, Shulei
    Zhang, Lin
    Han, Yuchen
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 76 - 80
  • [43] 9q34.3 microduplications lead to neurodevelopmental disorders through EHMT1 overexpression
    Maria Teresa Bonati
    Chiara Castronovo
    Alessandra Sironi
    Dario Zimbalatti
    Ilaria Bestetti
    Milena Crippa
    Antonio Novelli
    Sara Loddo
    Maria Lisa Dentici
    Juliet Taylor
    Françoise Devillard
    Lidia Larizza
    Palma Finelli
    neurogenetics, 2019, 20 : 145 - 154
  • [44] 9q34.3 microduplications lead to Neurodevelopmental Disorders through EHMT1 overexpression
    Sironi, A.
    Bonati, M. T.
    Castronovo, C.
    Zimbalatti, D.
    Crippa, M.
    Bestetti, I.
    Rosenfeld, J. A.
    Scott, D. A.
    Stankiewicz, P.
    Novelli, A.
    Loddo, S.
    Taylor, J.
    Devillard, F.
    Larizza, L.
    Finelli, P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1386 - 1386
  • [45] Deep intronic de novo germline EHMT1 variant in a patient with syndromic developmental delay
    Peters, Sophia
    Schmidt, Axel
    Bender, Tim
    Cremer, Kirsten
    Perne, Claudia
    Mangold, Elisabeth
    Raschke, Heidrun
    Heimbach, Andre
    Sivalingam, Sugirthan
    Krawitz, Peter
    Engels, Hartmut
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 173 - 173
  • [46] 9q34.3 microduplications lead to neurodevelopmental disorders through EHMT1 overexpression
    Bonati, Maria Teresa
    Castronovo, Chiara
    Sironi, Alessandra
    Zimbalatti, Dario
    Bestetti, Ilaria
    Crippa, Milena
    Novelli, Antonio
    Loddo, Sara
    Dentici, Maria Lisa
    Taylor, Juliet
    Devillard, Francoise
    Larizza, Lidia
    Finelli, Palma
    NEUROGENETICS, 2019, 20 (03) : 145 - 154
  • [47] Essential roles of histone lysine methyltransferases EZH2 and EHMT1 in male embryo development of Phenacoccus solenopsis
    Tong, Haojie
    Omar, Mohamed A. A.
    Wang, Yuan
    Li, Meizhen
    Li, Zicheng
    Li, Zihao
    Ao, Yan
    Wang, Ying
    Jiang, Mingxing
    Li, Fei
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [48] Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
    Watson, Zachary L.
    Yamamoto, Tomomi M.
    Hughes, Connor J.
    Wheeler, Lindsay J.
    Post, Miriam D.
    Behbakht, Kian
    Bitler, Benjamin G.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 77 - 78
  • [49] Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death
    Silva-Carvalho, Amandda Evelin
    Dorneles Alencar, Ana Paula
    Resende, Marielly Reis
    da Costa, Daniel Freitas
    Nonino, Alexandre
    Rocha Neves, Francisco Assis
    Saldanha-Araujo, Felipe
    TOXICOLOGY IN VITRO, 2020, 69
  • [50] Tourette-like syndrome secondary to Kleefstra syndrome 1 with a de novo microdeletion in the EHMT1 gene
    Niu, Mengyue
    Li, Yanjing
    Zhan, Shikun
    Sun, Bomin
    Liu, Jun
    Wu, Yiwen
    BMC NEUROLOGY, 2023, 23 (01)